Kfs Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 46.44%
- Profit Growth -13.11%
- Ebitda -78.69%
- Net Worth 77.72%
- Total Assets 57.95%
About Kfs Biotech
Kfs Biotech Private Limited (KBPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 June 2020 (Four years and eight months 22 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.00 M.
Khem Chand and Saleem Khan serve as directors at the Company.
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900HP2020PTC007895
- Company No.
007895
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Kfs Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Khem Chand  | Director | 04-Jun-2020 | Current |
| Saleem Khan | Director | 04-Jun-2020 | Current |
Financial Performance of Kfs Biotech.
Kfs Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 46.44% increase. The company also saw a substantial fall in profitability, with a 13.11% decrease in profit. The company's net worth Soared by an impressive increase of 77.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kfs Biotech?
In 2022, Kfs Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Mar 2023 | State Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Kfs Biotech?
Unlock and access historical data on people associated with Kfs Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kfs Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kfs Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.